Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · IEX Real-Time Price · USD
1.430
-0.100 (-6.54%)
Jul 22, 2024, 10:14 AM EDT - Market open

Intelligent Bio Solutions Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Year Ending
CurrentJun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019
Market Capitalization
551049--
Market Cap Growth
240.59%-51.14%-79.80%---
Enterprise Value
-4523655
PE Ratio
--0.45-1.19-6.93--
PS Ratio
1.482.4222.5524.63--
PB Ratio
0.431.271.493.24--
P/FCF Ratio
-1.17-0.61-2.64-4.32--
P/OCF Ratio
-1.26-0.65-2.94-4.32--
EV/Sales Ratio
0.192.313.7018.2824.9426241.53
EV/EBITDA Ratio
-0.07-0.49-0.20-6.09-1.74-0.74
EV/EBIT Ratio
-0.06-0.44-0.20-6.09-1.74-0.74
EV/FCF Ratio
-0.08-0.59-0.43-3.21-9.44-0.88
Debt / Equity Ratio
0.080.35---0.99-1.29
Debt / EBITDA Ratio
-0.11-0.14---1.90-0.77
Debt / FCF Ratio
-0.12-0.17---10.30-0.92
Quick Ratio
1.720.312.004.270.060.03
Current Ratio
2.020.662.334.940.300.37
Asset Turnover
0.290.160.030.130.08-
Interest Coverage
-57.27-46.56-1100.74-5.43-5.91-10.04
Return on Equity (ROE)
-205.10%-167.00%-85.10%-60.20%69.00%-
Return on Assets (ROA)
-89.30%-86.40%-54.40%-45.30%-131.70%-
Return on Capital (ROIC)
-84.32%-245.30%-125.84%-37.01%5409.85%-583.48%
Earnings Yield
-210.34%-220.73%-84.26%-14.42%--
FCF Yield
-162.95%-163.65%-37.92%-23.16%--
Buyback Yield / Dilution
-2151.20%-37.00%-40.81%-22.38%-1.52%-
Total Shareholder Return
-2151.20%-37.00%-40.81%-22.38%-1.52%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).